Grading of chemotherapy-induced peripheral neuropathy
Open Access
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (5) , 509-514
- https://doi.org/10.1023/a:1008345613594
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian CancerGynecologic Oncology, 1997
- Neurotoxicity of cisplatin +/- reduced glutathione in the first-line treatment of advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- Neurotrophic factors in peripheral neuropathies: Pharmacological strategiesProgress in Neurobiology, 1996
- Outcome research in neurology: Incorporating health‐related quality of lifeAnnals of Neurology, 1995
- Examination of distal involvement in cisplatin-induced neuropathy in manBrain, 1993
- Assessing the Reliability of Two Toxicity Scales: Implications for Interpreting Toxicity DataJNCI Journal of the National Cancer Institute, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Prospective nerve conduction studies in cisplatin therapyAnnals of Neurology, 1988
- Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometryAnnals of Neurology, 1980